[1]胡晓文,李桂霞,俞徽,等.蛭龙胶囊对糖尿病肾病V期患者微炎症指标的影响[J].西部中医药,2017,30(04):88-90.
 HU Xiaowen,LI Guixia,YU Hui,et al.The Influence of ZhiLong Capsule on Micro Inflammation Indexes of Patients with Diabetic Nephropathy in V Stage[J].Western Journal of Traditional Chinese Medicine,2017,30(04):88-90.
点击复制

蛭龙胶囊对糖尿病肾病V期患者微炎症指标的影响()
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
30
期数:
2017年04期
页码:
88-90
栏目:
出版日期:
2017-04-15

文章信息/Info

Title:
The Influence of ZhiLong Capsule on Micro Inflammation Indexes of Patients with Diabetic Nephropathy in V Stage
文章编号:
1004-6852(2017)04-0088-03
作者:
胡晓文1李桂霞1俞徽1许筠2△
1 甘肃中医药大学,甘肃 兰州730000; 2 兰州市第二人民医院
Author(s):
HU Xiaowen1, LI Guixia1, YU Hui1, XU Jun2△
1 Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China; 2 The Second People′s Hospital of Lanzhou
关键词:
蛭龙胶囊微炎症糖尿病肾病
Keywords:
ZhiLong Capsule micro inflammation diabetic nephropathy
分类号:
R587.1
文献标志码:
B
摘要:
目的:观察蛭龙胶囊对糖尿病肾病(DN)V期患者微炎症指标的影响。方法:将78例患者随机分为2组,对照组38例,给予常规治疗;观察组40例,在常规治疗组的基础上加用蛭龙胶囊。观察治疗前后2组患者血清超敏C反应蛋白(hs-CRP)、肿瘤坏死因子α(TNF-α)、白介素6(IL-6)、同型半胱氨酸(Hcy)的变化情况。选取健康对照组40例,比较其与糖尿病肾病V期患者hs-CRP、TNF-α、IL-6、Hcy水平的差异。结果:治疗前hs-CRP、TNF-α、IL-6、Hcy水平观察组、对照组与健康对照组比较,差异均有统计学意义(P<0.05)。治疗前后hs-CRP、IL-6、TNF-α水平观察组、对照组组内比较,差异有统计学意义;Hcy水平观察组治疗前后比较,差异有统计学意义(P<0.05)。治疗后hs-CRP、TNF-α、IL-6、Hcy水平观察组与对照组比较,差异有统计学意义(P<0.05)。结论:蛭龙胶囊可改善V期DN患者的微炎症状态,下调正性炎性时相反应蛋白水平,改善氧化应激,从而减轻肾脏损害。
Abstract:
Objective: To investigate the influence of ZhiLong Capsule on micro inflammation indexes of patients with diabetic nephropathy in V stage. Methods: 78 patients were randomly divided into two groups, and the control group (38 cases) was given conventional treatment. Based on the treatment of the control group, the observation group (40 cases) was added ZhiLong Capsule treatment. Changes of serum levels of high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and homocysteine (Hcy) of two groups were observed before and after treatment. The differences of levels of hs-CRP, TNF-α, IL-6 and Hcy of patients with diabetic nephropathy in V stage were compared with 40 cases in healthy control group. Results: Compared the levels of hs-CRP, TNF-α, IL-6 and Hcy between the observation group and the control group,and healthy control group before treatment, the differences were statistically significant(P<0.05). Compared the levels of hs-CRP, TNF-α, and IL-6 within the observation group and the control group between before and after treatment, the differences were statistically significant. Compared the Hcy levels within the observation group before and after treatment, the differences were statistically significant (P<0.05). Compared the levels of hs-CRP, TNF-α, IL-6 and Hcy between the observation group and the control group after treatment, the differences were statistically significant (P<0.05). Conclusion: ZhiLong capsule can improve the micro inflammation symptoms of DN patients in V stage, decrease reactive protein level of positive inflammatory phase and improve oxidative stress to relieve renal damage.

相似文献/References:

[1]徐家玥,许筠△,张茹,等.蛭龙胶囊对早期糖尿病肾病大鼠肾纤维化的影响*[J].西部中医药,2013,26(01):9.
 XU Jiayue,XU Jun,ZHA NG Ru,et al.Effects of ZhiLong Capsule on Renal Fibrosis of Rats with Early-stage Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(04):9.

备注/Memo

备注/Memo:
收稿日期:2016-11-19 作者简介:胡晓文(1991—),女,在读硕士研究生。研究方向:肾病与糖尿病的中西医结合防治。 △通讯作者:许筠(1963—),女,硕士研究生导师,主任医师。研究方向:肾病与糖尿病的中西医结合防治。
更新日期/Last Update: 2017-04-15